Polyvinylpyrrolidone (PVP K30)
(Synonyms: 聚乙烯吡咯烷酮; PVP; Polyvidone; Povidone) 目录号 : GC32133
Polyvinylpyrrolidone (PVP, Polyvidone, Povidone) is an inert, water-soluble, non-toxic, temperature-resistant, pH-stable, biocompatible, biodegradable polymer that helps to encapsulate and cater both hydrophilic and lipophilic drugs. Polyvinylpyrrolidone has been widely tested and used as an effective wound healing accelerator.
Cas No.:9003-39-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
|
Animal experiment: |
Each fish within a tank serves as a replicate. Treatments are designated as Polyvinylpyrrolidone (at a dose of 10 mL/10 gallon) and saline/salt at 3g/L. A control group that does not receive any chemical is also included in the study. All fishes from each treatment group are sampled at 0 min, 15 min, 1 h, 4 h and 25 h. At each time interval, all fishes from each treatment group are anaesthetized using buffered tricaine methanesulfonate, weighed, and slime is scraped from one 1 cm2 area over the epaxial musculature using a preweighed plastic coverslip[1]. |
|
References: [1]. Shivappa RB, et al. Laboratory evaluation of different formulations of Stress Coat for slime production in goldfish (Carassius auratus) and koi (Cyprinus carpio). PeerJ. 2017 Sep 6;5:e3759. |
|
Polyvinylpyrrolidone (PVP, Polyvidone, Povidone) is an inert, water-soluble, non-toxic, temperature-resistant, pH-stable, biocompatible, biodegradable polymer that helps to encapsulate and cater both hydrophilic and lipophilic drugs. Polyvinylpyrrolidone has been widely tested and used as an effective wound healing accelerator.
[1] Mallesh Kurakula, G S N Koteswara Rao. J Drug Deliv Sci Technol. 2020 Dec;60:102046. [2] Raghunath B Shivappa, et al. PeerJ. 2017 Sep 6;5:e3759.
| Cas No. | 9003-39-8 | SDF | |
| 别名 | 聚乙烯吡咯烷酮; PVP; Polyvidone; Povidone | ||
| Canonical SMILES | O=C1CCCN1C(C[H])[H].[n] | ||
| 分子式 | (C6H9NO)n | 分子量 | ~40,000 |
| 溶解度 | DMSO : 50 mg/mL ;Water : ≥ 50 mg/mL | 储存条件 | Store at RT |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Multifunctional Role of Polyvinylpyrrolidone in Pharmaceutical Formulations
AAPS PharmSciTech 2021 Jan 6;22(1):34.PMID:33404984DOI:10.1208/s12249-020-01909-4.
Polyvinylpyrrolidone (PVP), a non-ionic polymer, has been employed in multifarious fields such as paper, fibers and textiles, ceramics, and pharmaceutics due to its superior properties. Especially in pharmacy, the properties of inertness, non-toxicity, and biocompatibility make it a versatile excipient for both conventional formulations and novel controlled or targeted delivery systems, serving as a binder, coating agent, suspending agent, pore-former, solubilizer, stabilizer, etc. PVP with different molecular weights (MWs) and concentrations is used in a variety of formulations for different purposes. In this review, PVP-related researches mainly in recent 10 years were collected, and its main pharmaceutical applications were summarized as follows: (i) improving the bioavailability and stability of drugs, (ii) improving the physicomechanical properties of preparations, (iii) adjusting the release rate of drugs, and (iv) prolonging the in vivo circulation time of liposomes. Most of these applications could be explained by the viscosity, solubility, hydrophilicity, and hydrogen bond-forming ability of PVP, and the specific action mechanisms for each application were also tried to figure out. The effect of PVP on bioavailability improvement establishes it as a promising polymer in the emerging controlled or targeted formulations, attracting growing interest on it. Therefore, given its irreplaceability and tremendous opportunities for future developments, this review aims to provide an informative reference about current roles of PVP in pharmacy for interested readers.
Preparation and evaluation of chitosan/Polyvinylpyrrolidone/zein composite hemostatic sponges
Int J Biol Macromol 2022 Apr 30;205:110-117.PMID:35149100DOI:10.1016/j.ijbiomac.2022.02.013.
Trauma-related excessive bleeding is one of the leading causes of death. Chitosan (CS) sponges have unique advantages in the treatment of massive bleeding, but their application is limited by poor stability and toxic crosslinking agent. In this work, chitosan/Polyvinylpyrrolidone/zein (CS/PVP/Zein) sponges with macroporous structure were prepared, which exhibited rapid water absorption capacity and water-triggered expanding property with low cytotoxicity and low hemolysis ratio. In vitro blood coagulation experiments showed that CS/PVP/Zein sponges could clot blood significantly faster than commercial surgical gauze. Further investigation of the hemostatic mechanism suggested that the CS/PVP/Zein sponges could accelerate coagulation by promoting attachment of erythrocytes, activation of platelets, and rapid plasma protein absorption. Prepared sponges were also found effective in the rat femoral artery transection model to control bleeding. Overall, the CS/PVP/Zein sponges exhibited the potential to control trauma-related hemorrhage.
Polyvinylpyrrolidone in hemodialysis membranes: Impact on platelet loss during hemodialysis
Hemodial Int 2021 Oct;25(4):498-506.PMID:34085391DOI:10.1111/hdi.12939.
Introduction: Hydrophilic modification with Polyvinylpyrrolidone (PVP) increases the biocompatibility profile of synthetic dialysis membranes. However, PVP may be eluted into the patient's blood, which has been discussed as a possible cause for adverse reactions rarely occurring with synthetic membranes. We investigated the content of PVP and its elution from the blood-side surface from commercially available dialyzers, including the novel FX CorAL, with PVP-enriched and α-tocopherol-stabilized membrane, and link the results to the level of platelet loss during dialysis as a maker of biocompatibility. Methods: Six synthetic, PVP containing, dialyzers (FX CorAL, FX CorDiax [Fresenius Medical Care]; Polyflux, THERANOVA [Baxter]; ELISIO [Nipro]; xevonta [B. Braun]) were investigated in the present study. The content of PVP on blood-side surface was determined with X-ray photoelectron spectroscopy (XPS). The amount of elutable PVP was measured photometrically after 5 h recirculation. The level of platelet loss was evaluated in an ex vivo recirculation model with human blood. Findings: Highest PVP content on the blood-side surface was found for the polysulfone-based FX CorAL (26.3%), while the polyethersulfone-based THERANOVA (15.6%) had the lowest PVP content. Elution of PVP was highest for the autoclave steam-sterilized THERANOVA (9.1 mg/1.6 m2 dialyzer) and Polyflux (9.0 mg/1.6 m2 dialyzer), while the lowest PVP elution was found for the INLINE steam sterilized FX CorAL and FX CorDiax (<0.5 mg/1.6 m2 dialyzer, for both). Highest platelet loss was found for xevonta (+164.4% compared to the reference) and the lowest for the FX CorAL (-225.2%) among the polysulfone-based dialyzers; among the polyethersulfone-based dialyzers, THERANOVA (+95.5%) had the highest and ELISIO (-52.1%) the lowest platelet loss. Discussion: Polyvinylpyrrolidone content and elution differ between commercially available dialyzers and were found to be linked to the membrane material and sterilization method. The amount of non-eluted PVP on the blood-side surface may be an important determinant for the biocompatibility of dialyzers.
Polyvinylpyrrolidone (PVP) mitigates the damaging effects of intracellular ice formation in adult stem cells
Ann Biomed Eng 2010 May;38(5):1826-35.PMID:20177781DOI:10.1007/s10439-010-9963-z.
The objective of this work was to assess the effect of 10% (w/v) Polyvinylpyrrolidone (PVP) on the pattern of intracellular ice formation (IIF) in human adipose tissue derived adult stem cells (ASCs) in the absence of serum and other cryoprotective agents (CPAs). The freezing experiments were carried out using a fluorescence microscope equipped with a Linkam cooling stage using two cooling protocols. Both the cooling protocols had a common cooling ramp: cells were cooled from 20 degrees C to -8 degrees C at 20 degrees C/min and then further cooled to -13 degrees C at 1 degrees C/min. At this point we employed either cooling protocol 1: the cells were cooled from -13 degrees C to -40 degrees C at a pre-determined cooling rate of 1, 5, 10, 20, or 40 degrees C/min and then thawed back to 20 degrees C at 20 degrees C/min; or cooling protocol 2: the cells were re-warmed from -13 degrees C to -5 degrees C at 20 degrees C/min and then re-cooled at a pre-determined rate of 1, 5, 10, 20, or 40 degrees C/min to -40 degrees C. Almost all (>95%) of the ASCs frozen in 1x PBS and protocol 1 exhibited IIF. However, almost none (<5%) of the ASCs frozen in 1x PBS and protocol 2 exhibited IIF. Similarly, almost all (>95%) of the ASCs frozen in 10% PVP in PBS and protocol 1 exhibited IIF. However, ~0, ~40, ~47, ~67, and ~100% of the ASCs exhibited IIF when frozen in 10% PVP in PBS and utilizing protocol 2 at a cooling rate of 1, 5, 10, 20, or 40 degrees C/min, respectively.
Preparation and characterization of bioactive polyvinylpyrrolidone film via electrospinning technique
Microsc Res Tech 2022 Oct;85(10):3347-3355.PMID:35790058DOI:10.1002/jemt.24189.
Electrospinning technique became a very common and effective method to fabricate nonwoven films with a large surface area for different purposes especially in the biomedical field. Antimicrobial submicron fibrous films based on Polyvinylpyrrolidone (PVP) doped with silver nanoparticles (Ag-NPs), Zinc Oxide (ZnO), and (Ag-NPS/ZnO), were successfully fabricated via the electrospinning technique. The morphology and the elemental configurations of the as-prepared films were studied by using scanning electron microscope with EDX. While the phase formation and crystal structures were determined by using XRD analysis. The antibacterial effect was investigated against one of the most common Gram-negative bacteria Klebsiella pneumoniae by using a modified Kirby-Bauer disc diffusion method. The results showed that the doping nanoparticles were uniformly loaded on the surface of the fabricated film fibers. By using Scherrer equation the calculated average crystallite sizes of Ag-NPs, ZnO, and Ag-NPs/ZnO on PVP fibers were 63, 30, and 44 nm, respectively. The antimicrobial activity against Klebsiella pneumoniae showed the growth inhibition zones in the bacteria plates of 23.3, 54, and 60.6 mm for the samples of Ag-NPs/PVP, ZnO/PVP, and Ag-NPs/ZnO/PVP, respectively. The antimicrobial efficiency increased by forming nanocomposites of both ZnO nanoparticles and Ag nanoparticles inside the film. RESEARCH HIGHLIGHTS: Novel antimicrobial submicron electrospun membranes based on polyvinylpyrrolidone doped with silver, zinc oxide nanoparticles were successfully fabricated. The fabricated samples showed bactericidal activity against K. pneumoniae.